WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 11'259  11'266  11'271  11'276  11'282  11'138  10'601  9'835 
Births 106  107  108  110  112  145  177  159 
Surviving infants 105  107  108  109  111  144  175  156 
Pop. less than 5 years 529  529  532  545  570  731  898  803 
Pop. less than 15 years 1'791  1'827  1'862  1'902  1'953  2'411  2'457  3'116 
Female 15-49 years 2'810  2'863  2'915  2'958  2'988  3'024  2'946  2'433 

Number of reported case

(Click for retrospective incidence data for Cuba)
Diphtheria
Japanese encephalitis
Measles 12  3'924 
Mumps
Pertussis 70  131 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 26 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cuba)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   95  99  99*  99*  99  99  99  98  99 
DTP1 2009  99  MICS   95  98  95  99*  99*  96  93 
DTP3 2009  97  MICS   95  99*  96  99*  99*  96  95  92  67 
DTP4          99* 
IPV1         
HepB_BD          99  99*  99  99  99  99 
HepB3 2009  97  MICS   95  99*  96  99*  99*  96  98 
Hib3 2009  97  MICS   95  99*  96  99*  99*  96  78 
JapEnc         
MCV1          99*  99*  99*  99*  99*  94  94  48 
MCV2          99*  99*  99*  95  98 
PCV1         
PCV3         
Pol3          99*  98  98  99*  99*  99  94  99 
Rota1         
Rota_last         
Rubella1          99*  99*  99*  99*  99* 
TT2plus          65  17  71  55  77 
PAB         
VAD1         
YFV          99* 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cuba)
BCG 99  99  99  99  99  99  98  99 
DTP1 98  98  98  96  96  98  97  86 
DTP3 96  96  96  96  96  95  92  67 
HepB3 96  96  96  96  96  98 
HepB_BD 99  99  99  99  99  99 
Hib3 96  96  96  96  96  99 
MCV1 99  99  99  99  99  94  94  48 
MCV2 95  95  95  95  98 
PCV3
Pol3 99  98  98  99  99  98  94  99 
Rota_last

Number of districts in the country 168  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 99
From 80 to 89% 1
From 50 to 79% 1
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
DT 6 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Pediatric birth; Yes
Hib 18 months; Yes
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
MMR 12 months; 6 years; Yes
MenBC 3, 5 months; Yes
OPV <1, 1, 2, 9 years; Yes
TT 15 years; Yes
Typhoid 10, 13, 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2012-2016  2011-2012  2010-2015  2011-2015  2005-2010  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 168  168  168 

System performance

Total Nº districts in country number 168  168  168  168  169  169  169 
Nº districts with DTP3 coverage >=80% number 167  162  168  168  143  154  166 
% of districts with DTP3 coverage >=80% From 0 to 100% 99  96  100  100  85  91  98 
Nº districts with measles (MCV1) coverage >=95% number 157  154  152  154  130  141  157 
% of districts with MCV1 coverage >=95% From 0 to 100% 93  92  90  92  77  83  93 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  99  99  99  98  100  98 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.